Select Page

Company to buy

  • Size: small sized business
  • Revenue: 3 – 10 million EUR
  • Location of the target company: any country of Europe
  • Reason for acquisition: The company ants to add external growth to organic growth
  • #CFIE PHB057

Overview of this buyer for an oncology CRO

A profitable CRO based in the Benelux region, which expanded its services organically in the recent past, is now looking to purchase a similar-sized company as part of its continuing expansion plans. The company is looking at any European country with a stable portfolio of customers and a positive growth outlook.

Profile (strategy) of this oncology CRO buyer

The buyer is a well-established management, consultancy and contract research company based in Europe, specialized in serving top clients in the pharmaceutical industry and healthcare sector. The company serves governmental institutions, but also private companies. The company is operating on a European level, having offices in multiple countries of Europe.

The company is providing professional services in areas such as:

  • medical consultancy
  • medical device consulting
  • clinical research
  • clinical studies
  • drug development consultancy etc.

The company is an expert in multiple disciplines, such as:

  • Oncology
  • Ophthalmology
  • Haematology
  • Cardiology
  • Immunology
  • Gastroenterology
  • Respiratory diseases and many more.
Subscribe as an interested seller
Contact us to get details about this buyer for an oncology cro in europe

Activities and products of an ideal target CRO

This buyer company is planning to grow externally by M&A in the near future, which would boost the growth of the services portfolio. Therefore, they are looking for a CRO company in Europe, in order to acquire or merge. It would be ideal if the CRO had experience with oncology or similar discipline.

Geographically, the buyer is looking at all countries and will be willing to consider any country, but central Europe, countries like Germany or Austria will be preferred.

The target should be experienced and have a good track record. The current management would stay in place preferably after the acquisition. The current revenue or financials of the company are not as decisive, on the other hand, the target should not be in loss or in significant debt. It is important to have a professional team with a successful project history.

Highlights of this contract research organization buyer

  • The buyer is a CRO company looking for targets which could help them with expansion in Europe
  • The target company should be any contract research organization (CRO) in Europe with a good track record
  • The buyer is open to a full acquisition or a majority investment, the structure can be a subject of discussion

More information on this buyer for an oncology CRO in Europe

Please get in touch if you are interested in learning more about this buyer for an oncology CRO in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.

Subscribe as a seller for this Pharma buyer

en_GBEnglish (UK)